Suppr超能文献

二甲双胍可降低多囊卵巢综合征妇女子宫内膜中雄激素受体的表达并上调同源盒 A10 的表达。

Metformin reduces androgen receptor and upregulates homeobox A10 expression in uterine endometrium in women with polycystic ovary syndrome.

机构信息

Department of Obstetrics and Gynecology, Fukushima Medical University, School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Center for Gender Specific Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

出版信息

Reprod Biol Endocrinol. 2021 May 31;19(1):77. doi: 10.1186/s12958-021-00765-6.

Abstract

BACKGROUND

Polycystic ovary syndrome (PCOS) causes anovulation and is associated with a reduced clinical pregnancy rate. Metformin, which is widely used for treating PCOS, can lead to successful pregnancy by restoring the ovulation cycle and possibly improving endometrial abnormality during the implantation period. However, the mechanism by which metformin improves endometrial abnormality remains unknown. Women with PCOS have an aberrant expression of steroid hormone receptors and homeobox A10 (HOXA10), which is essential for embryo implantation in the endometrium.

METHODS

In this study, we examined whether metformin affects androgen receptor (AR) and HOXA10 expression in PCOS endometrium in vivo and in human endometrial cell lines in vitro. Expression of AR and HOXA10 was evaluated by immunohistochemistry, fluorescent immunocytochemistry, and western blot analysis.

RESULTS

AR expression was localized in both epithelial and stromal cells; however, HOXA10 expression was limited to only stromal cells in this study. In women with PCOS, 3 months after metformin treatment, the expression of AR was reduced in epithelial and stromal cells in comparison to their levels before treatment. In contrast, HOXA10 expression in the stromal cells with metformin treatment increased in comparison to its level before treatment. Further, we showed that metformin counteracted the testosterone-induced AR expression in both Ishikawa cells and human endometrial stromal cells (HESCs); whereas, metformin partly restored the testosterone-reduced HOXA10 expression in HESCs in vitro.

CONCLUSIONS

Our results suggest that metformin may have a direct effect on the abnormal endometrial environment of androgen excess in women with PCOS.

TRIAL REGISTRATION

The study was approved by the Ethical Committee of Fukushima Medical University (approval no. 504, approval date. July 6, 2006), and written informed consent was obtained from all patients. https://www.fmu.ac.jp/univ/sangaku/rinri.html.

摘要

背景

多囊卵巢综合征(PCOS)导致排卵障碍,并与临床妊娠率降低有关。二甲双胍广泛用于治疗 PCOS,它可以通过恢复排卵周期并可能改善着床期子宫内膜异常,从而导致成功妊娠。然而,二甲双胍改善子宫内膜异常的机制尚不清楚。患有 PCOS 的女性存在类固醇激素受体和同源盒 A10(HOXA10)的异常表达,这对于胚胎在子宫内膜中的着床是必不可少的。

方法

在这项研究中,我们研究了二甲双胍是否会影响体内 PCOS 子宫内膜和体外人子宫内膜细胞系中的雄激素受体(AR)和 HOXA10 的表达。通过免疫组织化学、荧光免疫细胞化学和 Western blot 分析评估 AR 和 HOXA10 的表达。

结果

AR 表达定位于上皮细胞和基质细胞;然而,在本研究中,HOXA10 表达仅局限于基质细胞。在患有 PCOS 的女性中,与治疗前相比,在接受二甲双胍治疗 3 个月后,上皮细胞和基质细胞中的 AR 表达减少。相比之下,接受二甲双胍治疗的基质细胞中 HOXA10 的表达与治疗前相比增加。此外,我们表明二甲双胍可拮抗睾酮诱导的 Ishikawa 细胞和人子宫内膜基质细胞(HESCs)中的 AR 表达;然而,二甲双胍部分恢复了 HESCs 中睾酮降低的 HOXA10 表达。

结论

我们的结果表明,二甲双胍可能对患有 PCOS 的女性雄激素过多的异常子宫内膜环境具有直接作用。

试验注册

该研究得到了福岛医科大学伦理委员会的批准(批准号 504,批准日期为 2006 年 7 月 6 日),并获得了所有患者的书面知情同意。https://www.fmu.ac.jp/univ/sangaku/rinri.html。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef12/8165781/7dcd75884c78/12958_2021_765_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验